메뉴 건너뛰기
Medecine/Sciences
Volumn 24, Issue 6-7, 2008, Pages 579-580
VEGF111: Dr Jekyll and Mr Hyde?;VEGF111: Dr Jekyll et Mr Hyde?
Author keywords

[No Author keywords available]
Indexed keywords

BEVACIZUMAB; CAMPTOTHECIN; VASCULOTROPIN; VASCULOTROPIN 111;
EID: 47749117224     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20082467579     Document Type: Note
Times cited : (2)
References (9)
  • 1
    • 34347245241 scopus 로고    scopus 로고
    • Clinical and fundamental aspects of angiogenesis and antiangiogenesis
    • Buysschaert I, Carmeliet P, Dewerchin M. Clinical and fundamental aspects of angiogenesis and antiangiogenesis. Acta Clin Belg 2007 ; 62 : 162-9.
    • (2007) Acta Clin Belg , vol.62 , pp. 162-169
    • Buysschaert, I.1    Carmeliet, P.2    Dewerchin, M.3
  • 2
    • 0029937679 scopus 로고    scopus 로고
    • The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
    • Keyt BA, Berleau LT, Nguyen HV, et al. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 1996 ; 271 : 7788-95.
    • (1996) J Biol Chem , vol.271 , pp. 7788-7795
    • Keyt, B.A.1    Berleau, L.T.2    Nguyen, H.V.3
  • 3
    • 22344437713 scopus 로고    scopus 로고
    • Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors
    • Lee S, Jilani SM, Nikolova GV, et al. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 2005 ; 169 : 681-91.
    • (2005) J Cell Biol , vol.169 , pp. 681-691
    • Lee, S.1    Jilani, S.M.2    Nikolova, G.V.3
  • 4
    • 37249059009 scopus 로고    scopus 로고
    • Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents
    • Mineur P, Colige AC, Deroanne CF, et al. Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. J Cell Biol 2007 ; 179 : 1261-73.
    • (2007) J Cell Biol , vol.179 , pp. 1261-1273
    • Mineur, P.1    Colige, A.C.2    Deroanne, C.F.3
  • 5
    • 0033910462 scopus 로고    scopus 로고
    • Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds
    • Lauer G, Sollberg S, Cole M, et al. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 2000; 115 : 12-8.
    • (2000) J Invest Dermatol , vol.115 , pp. 12-18
    • Lauer, G.1    Sollberg, S.2    Cole, M.3
  • 6
    • 33144457649 scopus 로고    scopus 로고
    • Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair
    • Roth D, Piekarek M, Paulsson M, et al. Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Am J Pathol 2006 ; 168 : 670-84.
    • (2006) Am J Pathol , vol.168 , pp. 670-684
    • Roth, D.1    Piekarek, M.2    Paulsson, M.3
  • 7
    • 85013312416 scopus 로고
    • Tumor angiogenesis: Therapeutic implications
    • Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971 ; 285 : 1182-6.
    • (1971) N Engl J Med , vol.285 , pp. 1182-1186
    • Folkman, J.1
  • 8
    • 15444371558 scopus 로고    scopus 로고
    • Épissage alternatif, pathologie et thérapeutique moléculaire.
    • Corcos L, Solier S. Épissage alternatif, pathologie et thérapeutique moléculaire. Med Sci (Paris) 2005 ; 21 : 253-60.
    • (2005) Med Sci (Paris) , vol.21 , pp. 253-260
    • Corcos, L.1    Solier, S.2
  • 9
    • 34547852903 scopus 로고    scopus 로고
    • SR proteins as potential targets for therapy
    • Soret J, Gabut M, Tazi J. SR proteins as potential targets for therapy. Prog Mol Subcell Biol 2006 ; 44 : 65-87.
    • (2006) Prog Mol Subcell Biol , vol.44 , pp. 65-87
    • Soret, J.1    Gabut, M.2    Tazi, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.